Hans-Joachim Hindenburg

Phase II Study of Capecitabine Plus Trastuzumab in Human Epidermal Growth Factor Receptor 2–Overexpressing Metastatic Breast Cancer Pretreated With Anthracyclines or Taxanes

Gerhard Schäller, Ilka Fuchs, Thomas Gonsch et al. · Journal of Clinical Oncology · 2007 · 100 citations · Full text

Medicine, Oncology, Pharmacology +17

A phase II study of topotecan plus gemcitabine in the treatment of patients with relapsed ovarian cancer after failure of first-line chemotherapy

Jalid Sehouli, Dirk Stengel, G. Oskay et al. · Annals of Oncology · 2002 · 33 citations · Full text

Medicine, Gynecology, Oncology +15

Biweekly pegylated liposomal doxorubicin in patients with relapsed ovarian cancer: results of a multicenter phase-II trial

Jalid Sehouli, Gülten Oskay-Özcelik, Jan Felix Kuhne et al. · Annals of Oncology · 2006 · 30 citations

Medicine, Oncology, Pharmacology +15

Efficacy and safety of trastuzumab plus capecitabine in a German multicentre phase II study of pre-treated metastatic breast cancer

G. Eric Schaller, N. Bangemann, Jan Weber et al. · Journal of Clinical Oncology · 2005 · 19 citations

Medicine, Oncology, Pharmacology +17

Weekly paclitaxel plus trastuzumab in metastatic breast cancer pretreated with anthracyclines-a phase II multipractice study

Matthias John, Axel Hinke, Martina Stauch et al. · BMC Cancer · 2012 · 17 citations · Full text

Medicine, Oncology, Pharmacology +17